Login to Your Account

Rare Diseases Research Not so Rare After FDASIA

By Peter Winter

Monday, July 16, 2012

With the stroke of a pen the prospects of millions of people suffering from rare diseases has improved dramatically. The signing of the Food and Drug Administration Safety and Innovation Act (FDASIA) by President Obama now gives the FDA the provision to work on speeding up the development of "breakthrough therapies" that demonstrate early promise and faster patient access to new medical treatments.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription